Intravenous (IV) Decitabine and Oral Bexarotene for Acute Myelogenous Leukemia (AML)

Clinical trial NCT01001143 · COMPLETED

Trial details

NCT number: NCT01001143
Sponsor: Washington University School of Medicine
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute

Start date: 2010-05-01
Primary completion: 2013-05-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.